OBJECTIVE: This study aimed to describe the prevalence and concordance between cervical and anal human papillomavirus (HPV) infection and compare cervicovaginal and anal self-collection methods for HPV testing between physician and self-collected specimens in women in Puerto Rico. MATERIALS AND METHODS: Specimens for HPV-DNA testing were obtained from 100 women aged 18 to 34 years attending a general gynecology clinic for a routine Pap smear. Human papillomavirus testing was performed using polymerase chain reaction MY09/MY11 primers. Positive samples were typed for 39 genotypes. Agreement between sampling methods was determined by percent agreement and the κ statistic. RESULTS: For the 39 genotypes evaluated, 38.4% (38/99) of cervicovaginal and 33.7% (30/89) of anal physician-collected samples were HPV+, whereas 35.1% (34/97) of cervicovaginal and 32.0% (31/97) of anal self-collected samples were positive. Human papillomavirus type 16 was the most common type identified in the cervix (8.3%, 8/97) and the anus (5.6%, 5/89) of physician-collected samples, with similar prevalence in self-collected samples. Concordance between cervical and anal HPV infection was high (>90%) for all types evaluated. There was a strong percent agreement between physician- and self-collected cervicovaginal and anal samples (>95% for all HPV types) and good to excellent agreement (κ > 0.60) for most HPV types. CONCLUSIONS: The clinic-based prevalence of anal and cervicovaginal HPV infection was high, with a strong concordance between cervical and anal infection and good to excellent agreement between physician- and self-collected samples. This study supports the feasibility of using cervical and anal self-sampling methods in future population-based studies of HPV infection in Puerto Rico and as an HPV screening method in women.
OBJECTIVE: This study aimed to describe the prevalence and concordance between cervical and anal human papillomavirus (HPV) infection and compare cervicovaginal and anal self-collection methods for HPV testing between physician and self-collected specimens in women in Puerto Rico. MATERIALS AND METHODS: Specimens for HPV-DNA testing were obtained from 100 women aged 18 to 34 years attending a general gynecology clinic for a routine Pap smear. Human papillomavirus testing was performed using polymerase chain reaction MY09/MY11 primers. Positive samples were typed for 39 genotypes. Agreement between sampling methods was determined by percent agreement and the κ statistic. RESULTS: For the 39 genotypes evaluated, 38.4% (38/99) of cervicovaginal and 33.7% (30/89) of anal physician-collected samples were HPV+, whereas 35.1% (34/97) of cervicovaginal and 32.0% (31/97) of anal self-collected samples were positive. Human papillomavirus type 16 was the most common type identified in the cervix (8.3%, 8/97) and the anus (5.6%, 5/89) of physician-collected samples, with similar prevalence in self-collected samples. Concordance between cervical and anal HPV infection was high (>90%) for all types evaluated. There was a strong percent agreement between physician- and self-collected cervicovaginal and anal samples (>95% for all HPV types) and good to excellent agreement (κ > 0.60) for most HPV types. CONCLUSIONS: The clinic-based prevalence of anal and cervicovaginal HPV infection was high, with a strong concordance between cervical and anal infection and good to excellent agreement between physician- and self-collected samples. This study supports the feasibility of using cervical and anal self-sampling methods in future population-based studies of HPV infection in Puerto Rico and as an HPV screening method in women.
Authors: Ana Patricia Ortiz; Marievelisse Soto-Salgado; Erick Suárez; María del Carmen Santos-Ortiz; Guillermo Tortolero-Luna; Cynthia M Pérez Journal: J Sex Med Date: 2011-06-15 Impact factor: 3.802
Authors: G S Ogilvie; D M Patrick; M Schulzer; J W Sellors; M Petric; K Chambers; R White; J M FitzGerald Journal: Sex Transm Infect Date: 2005-06 Impact factor: 3.519
Authors: P E Gravitt; J V Lacey; L A Brinton; W A Barnes; J R Kornegay; M D Greenberg; S M Greene; O C Hadjimichael; L McGowan; R Mortel; P E Schwartz; R Zaino; A Hildesheim Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-02 Impact factor: 4.254
Authors: Ross D Cranston; Teresa M Darragh; Elizabeth A Holly; Naomi Jay; J Michael Berry; Maria Da Costa; Jimmy T Efird; Joel M Palefsky Journal: J Acquir Immune Defic Syndr Date: 2004-08-01 Impact factor: 3.731
Authors: Francisco Garcia; Bel Barker; Carlos Santos; Elena Mendez Brown; Thomas Nuño; Anna Giuliano; John Davis Journal: Obstet Gynecol Date: 2003-08 Impact factor: 7.661
Authors: Jiafen Hu; Lynn R Budgeon; Nancy M Cladel; Karla Balogh; Roland Myers; Timothy K Cooper; Neil D Christensen Journal: J Gen Virol Date: 2015-12 Impact factor: 3.891
Authors: Chunqing Lin; Jiri Slama; Paula Gonzalez; Marc T Goodman; Ningshao Xia; Aimée R Kreimer; Ting Wu; Nancy A Hessol; Yurii Shvetsov; Ana P Ortiz; Beatriz Grinsztejn; Anna-Barbara Moscicki; Isabelle Heard; María Del Refugio González Losa; Erna M Kojic; Maarten F Schim van der Loeff; Feixue Wei; Adhemar Longatto-Filho; Zizipho A Mbulawa; Joel M Palefsky; Annette H Sohn; Brenda Y Hernandez; Katina Robison; Steve Simpson; Lois J Conley; Alexandra de Pokomandy; Marianne A B van der Sande; Racheal S Dube Mandishora; Lays P B Volpini; Alessandra Pierangeli; Byron Romero; Timothy Wilkin; Silvia Franceschi; Carmen Hidalgo-Tenorio; Reshmie A Ramautarsing; Ina U Park; Fernanda K Tso; Sheela Godbole; Kathleen W M D'Hauwers; Borek Sehnal; Lynette J Menezes; Sandra A Heráclio; Gary M Clifford Journal: Lancet Infect Dis Date: 2019-06-13 Impact factor: 25.071
Authors: Ana P Ortiz; Natalia Alejandro; Cynthia M Pérez; Yomayra Otero; Marievelisse Soto-Salgado; Joel M Palefsky; Guillermo Tortolero-Luna; Josefina Romaguera Journal: P R Health Sci J Date: 2012-12 Impact factor: 0.705
Authors: Vivian Colón-López; Ana P Ortiz; Marievelisse Soto-Salgado; Mariela Torres-Cintrón; Juan José Mercado-Acosta; Erick Suárez Journal: P R Health Sci J Date: 2013-06 Impact factor: 0.705
Authors: Eliane Rohner; Claire Edelman; Busola Sanusi; John W Schmitt; Anna Baker; Kirsty Chesko; Brian Faherty; Sean M Gregory; LaHoma S Romocki; Vijay Sivaraman; Julie A E Nelson; Siobhan O'Connor; Michael G Hudgens; Andrea K Knittel; Lisa Rahangdale; Jennifer S Smith Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-09-17 Impact factor: 4.254
Authors: A P Ortiz; V Tamayo; A Scorsone; M Soto-Salgado; I Febo; P Piovanetti; H L Venegas-Ríos; Y Yamamura; C Zorrilla Journal: Papillomavirus Res Date: 2017-06-19
Authors: Alan G Nyitray; Vanessa Schick; Michael D Swartz; Anna R Giuliano; Maria E Fernandez; Ashish A Deshmukh; Timothy J Ridolfi; Christopher Ajala; Bridgett Brzezinski; Micaela Sandoval; Belinda Nedjai; Jennifer S Smith; Elizabeth Y Chiao Journal: BMJ Open Date: 2021-06-29 Impact factor: 2.692
Authors: Serena A Rodriguez; Robin T Higashi; Andrea C Betts; Cynthia Ortiz; Jasmin A Tiro; Amneris E Luque; Arti Barnes Journal: J Low Genit Tract Dis Date: 2021-01-01 Impact factor: 3.842
Authors: A P Ortiz; J Romaguera; C M Pérez; D González; C Muñoz; L González; E Marrero; G Tortolero-Luna; E Suárez; J Palefsky Journal: Papillomavirus Res Date: 2016-04-26